Your browser doesn't support javascript.
loading
Clinical development and regulatory points for consideration for second-generation live attenuated dengue vaccines.
Vannice, Kirsten S; Wilder-Smith, Annelies; Barrett, Alan D T; Carrijo, Kalinka; Cavaleri, Marco; de Silva, Aravinda; Durbin, Anna P; Endy, Tim; Harris, Eva; Innis, Bruce L; Katzelnick, Leah C; Smith, Peter G; Sun, Wellington; Thomas, Stephen J; Hombach, Joachim.
Afiliação
  • Vannice KS; World Health Organization, Department of Immunizations, Vaccines and Biologicals, Geneva, Switzerland.
  • Wilder-Smith A; World Health Organization, Department of Immunizations, Vaccines and Biologicals, Geneva, Switzerland; Lee Kong Chian School of Medicine, Singapore.
  • Barrett ADT; Sealy Center for Vaccine Development and World Health Organization Collaborating Center for Vaccine Research, Evaluation and Training for Emerging Infectious Diseases, University of Texas Medical Branch, Galveston, TX, USA.
  • Carrijo K; Brazilian Health Regulatory Agency - Anvisa, Brasília, DF, Brazil.
  • Cavaleri M; European Medicines Agency, London, United Kingdom.
  • de Silva A; Department of Microbiology and Immunology, University of North Carolina School of Medicine, Chapel Hill, NC, USA.
  • Durbin AP; Center for Immunization Research, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA.
  • Endy T; State University of New York, Upstate Medical University, Syracuse, NY, USA.
  • Harris E; Division of Infectious Diseases and Vaccinology, School of Public Health, University of California, Berkeley, Berkeley, CA, USA.
  • Innis BL; Respiratory Infections and Maternal Immunizations, PATH Center for Vaccine Innovation and Access, Washington, DC, USA.
  • Katzelnick LC; Division of Infectious Diseases and Vaccinology, School of Public Health, University of California, Berkeley, Berkeley, CA, USA.
  • Smith PG; Tropical Epidemiology Group, London School of Hygiene & Tropical Medicine, London, United Kingdom.
  • Sun W; Food and Drug Administration, Silver Spring, MD, USA.
  • Thomas SJ; State University of New York, Upstate Medical University, Syracuse, NY, USA.
  • Hombach J; World Health Organization, Department of Immunizations, Vaccines and Biologicals, Geneva, Switzerland. Electronic address: hombachj@who.int.
Vaccine ; 36(24): 3411-3417, 2018 06 07.
Article em En | MEDLINE | ID: mdl-29525283
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Vacinação / Guias de Prática Clínica como Assunto / Dengue / Vacinas contra Dengue / Política de Saúde Tipo de estudo: Guideline / Prognostic_studies Limite: Humans Idioma: En Ano de publicação: 2018 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Vacinação / Guias de Prática Clínica como Assunto / Dengue / Vacinas contra Dengue / Política de Saúde Tipo de estudo: Guideline / Prognostic_studies Limite: Humans Idioma: En Ano de publicação: 2018 Tipo de documento: Article